This inventor holds 3 USPTO granted patents. Top assignees: A.p. Pharma, Inc., Advanced Polymer Systems, Inc., R.p. Scherer Corporation. Active years: 1999-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1999-2003
Title: Subhash J Saxena: Innovator in Pharmaceutical Formulations
Introduction
Subhash J Saxena is a notable inventor based in Belmont, CA (US), recognized for his contributions to pharmaceutical formulations. He holds 3 patents that showcase his innovative approach to drug delivery systems. His work primarily focuses on topical applications and softgel-compatible compositions.
Latest Patents
One of his latest patents is a formulation containing fluorouracil, which is designed as an oil-in-water emulsion. This formulation includes both free fluorouracil and fluorouracil impregnated in porous microparticles. It is particularly useful for treating solar keratoses, actinic keratoses, and superficial basal cell carcinomas. Another significant patent involves a softgel-compatible composition containing retinol. This composition features retinol-impregnated microparticles and may include thickened silicone oil or an emulsion with silicone oil. Additionally, ascorbic acid may be present in the form of impregnated microparticles or within the emulsion, making it suitable for various dispensing containers.
Career Highlights
Throughout his career, Subhash has worked with reputable companies such as Advanced Polymer Systems, Inc. and R.P. Scherer Corporation. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Subhash has collaborated with notable coworkers, including Marie A Rinaldi and Paul C Tutschek. Their combined efforts have further advanced the field of pharmaceutical formulations.
Conclusion
Subhash J Saxena's innovative work in pharmaceutical formulations has made a significant impact in the industry. His patents reflect a commitment to improving drug delivery systems for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile